A study to assess the contraceptive effectiveness of Sino-implant (II).
Drug: Sino-implant (II)
We will connect you to the doctor responsible for this trial and help you get more information.
Locations near you
Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Full eligibility criteria for NCT01594632
Ages eligible for Study
18 Years to 44 Years
Genders eligible for Study
Accepts Healthy Volunteers
• In good general health
Aged between 18 and 44 years, inclusive
Not wishing to become pregnant in the next five years
Request long-acting reversible contraception
If previously used injectable contraceptives for pregnancy prevention, be more than 9 months since last injection of Depo-Provera and more than 3 months after the last injection of a combined injectable contraceptive
If previously used LNG-containing oral pills or implants, be more than 1 week after last hormone intake or implant removal
Be able to understand the information provided and to make personal decisions on participation
Consent to participation and sign a consent form
Agree and be able to return to the clinic for follow-up visits over five years
acute deep venous thrombosis and/or pulmonary embolism or history of thromboembolic disease
systemic lupus erythematosus with positive or unknown antiphospholipid antibodies
unexplained vaginal bleeding
current or history of breast cancer
acute liver disease or cirrhosis
benign or malignant tumor of the liver
use of rifampicin, and/or anticonvulsants (barbiturates, phenytoin, phenobarbital, carbamazepine, oxcarbazepine, primidone, topiramate), and/or herbal products containing St. John's Wort (Hypericum perforatum)
more than one sexual partner in the last 3 months
diagnosis or treatment for a sexually transmitted infection (STI) within the past 30 days for her or partner (excluding recurrent genital herpes or condyloma)
known HIV positive status for her or partner
any condition (social or medical) which in the opinion of the Investigator would make study participation unsafe, would interfere with adherence to study requirements or complicate data interpretation
BMI greater than or equal to 30 (for the sub-group of women with intensive LNG sampling)
All locations for NCT01594632
Dominican Republic (1)
Santo Domingo, Dominican Republic
View full eligibility
Tris trial is registered with FDA with number: NCT01594632. The sponsor of the trial is FHI 360 and it is looking for 650 volunteers for the current phase.
Official trial title: A Study to Evaluate the Contraceptive Effectiveness, Safety and Acceptability of Sino-implant II
1What's a trial
4Get in touch
What's a trial
Not sure you're well informed about clinical trials? Learn more about their benefits, risks and other important details.
Enter your details like condition, age, gender and other preferences and we will show you a list of all relevant clinical trials.
Review the summary of the selected clinical trial and all the locations near you in order to see if it's of interest to you.
Get in touch
You've found an interesting trial? We'll need a bit more information about you so we can connect you to the doctor in charge.
Some people want to consult their doctor before considering participation in a clinical trial. This is absolutely normal as your doctor should know your medical history and should be able to advise you. If you want you can easily share the information for this trial with your doctor by clicking on the button below.